论文信息 - A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer - 字舞流文

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

D. Park | D. Seo | D. Han | Jung-shin Lee | Tark Kim | J. Lee | Song-Chul Kim | C. Yoo | J. Hwang | T. Kim | J. S. Lee | June-sung Kim | D. Han | S. K. Lee | S. Lee | S. Kim | Mh H. Kim | S. Lee | S. S. Lee | J. Kim | D. Seo | J.E. Kim | Min-Seon Kim | J. Hwang | Jong-Keuk Lee